TP53BP1 and neoplasm: Using organoids and γH2AX (or 53BP1) foci as a DSB marker may provide a novel venue to determine patient-specific tissue radiation response for an organ of interest, and be utilized to predict tumor control probability (TCP) and normal tissue complication probability (NTCP).